11月7日 - ** 再生医学制造商Organogenesis ORGO.O股价大涨54%至6美元
** 根据LSEG的数据，该公司周四晚些时候公布的第三季度产品收入为1.505亿美元，超过了分析师预计的1.341亿美元。
** 公司公布的调整后息税折旧摊销前利润（EBITDA）为3010万美元，高于预期的1740万美元。
** 截至上一交易日收盘，ORGO股价累计上涨85.9%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.